MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

Kodu・Aktsiate loetelu・VolitionRX Ltd

VolitionRX Ltd

Suletud

0.28 -3.45

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.28

Max

0.3

Põhinäitajad
By Trading Economics
Sissetulek	936K -5.4M
Müük	221K 627K
Kasumimarginaal	-857.414
Töötajad	75
EBITDA	1.3M -4.2M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+603.13% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	30. märts 2026

Turustatistika
By TradingEconomics
Turukapital	-5.1M 42M
Eelmine avamishind	3.73
Eelmine sulgemishind	0.28

VolitionRX Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. jaan 2026, 18:44 UTC

Suurimad hinnamuutused turgudel

Agenus Falls After $141 Million Zydus Deal Closes

15. jaan 2026, 17:51 UTC

Suurimad hinnamuutused turgudel

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

15. jaan 2026, 17:25 UTC

Suurimad hinnamuutused turgudel

ASML Exceeds $500 Billion in Market Value on TSMC's Blockbuster Spending Plans -- Update

15. jaan 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. jaan 2026, 23:48 UTC

Market Talk

Nikkei May Decline as Enthusiasm Over Election Eases -- Market Talk

15. jaan 2026, 23:40 UTC

Market Talk

Gold Edges Lower Amid Abating Geopolitical Risks -- Market Talk

15. jaan 2026, 23:11 UTC

Market Talk

Global Equities Roundup: Market Talk

15. jaan 2026, 23:11 UTC

Market Talk

Ryman Healthcare's Resales Remain Key Concern -- Market Talk

15. jaan 2026, 23:01 UTC

Market Talk

New Zealand's Economy Enters An Upswing -- Market Talk

15. jaan 2026, 22:56 UTC

Market Talk

Tulu

Catalyst Metals Delivers a Beat With Record Gold Output -- Market Talk

15. jaan 2026, 22:51 UTC

Market Talk

James Hardie's Plant Closures Could Boost Profit by 2%-3% -- Market Talk

15. jaan 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Verizon Gets Final California Approval to Secure $9.6 Billion Frontier Deal -- WSJ

15. jaan 2026, 21:50 UTC

Market Talk

Tulu

Financial Services Roundup: Market Talk

15. jaan 2026, 21:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Energy & Utilities Roundup: Market Talk

15. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15. jaan 2026, 21:27 UTC

Tulu

BlackRock Caps 2025 With Record $14 Trillion in Assets -- 3rd Update

15. jaan 2026, 21:15 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Global Commodities Roundup: Market Talk

15. jaan 2026, 21:11 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Global Equities Roundup: Market Talk

15. jaan 2026, 21:11 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Canada Antitrust Watchdog Confirms Review of Canadian Energy Deal -- Market Talk

15. jaan 2026, 20:10 UTC

Market Talk

U.S. Natural Gas Futures Settle Mixed -- Market Talk

15. jaan 2026, 20:04 UTC

Tulu

These Stocks Are Today's Movers: TSMC, ASML, Goldman, Morgan Stanley, BlackRock, Coinbase, Sandisk, and More -- Barrons.com

15. jaan 2026, 20:03 UTC

Market Talk

Oil Futures Fall As Iran Risk Premium Fades -- Market Talk

15. jaan 2026, 19:26 UTC

Market Talk

Silver Closes at Fresh High -- Market Talk

15. jaan 2026, 18:29 UTC

Suurimad hinnamuutused turgudel

Agenus Falls After $141M Zydus Deal Closes

15. jaan 2026, 18:20 UTC

Tulu

Wall Street Powers Nation's Biggest Banks to Record Year -- WSJ

15. jaan 2026, 17:56 UTC

Market Talk

Tulu

U.S. Bank Results Look Encouraging for European Peers -- Market Talk

15. jaan 2026, 17:20 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Auto & Transport Roundup: Market Talk

15. jaan 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

15. jaan 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

15. jaan 2026, 17:02 UTC

Omandamised, ülevõtmised, äriostud

KBC Group Completes Acquisition of 98.45% Stake in 365.bank From J&T Finance Group

Võrdlus sarnastega

Hinnamuutus

VolitionRX Ltd Prognoos

Hinnasiht

By TipRanks

603.13% tõus

12 kuu keskmine prognoos

Keskmine 2.25 USD 603.13%

Kõrge 3 USD

Madal 1.5 USD

Põhineb 3 Wall Streeti analüütiku instrumendi VolitionRX Ltd 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi VolitionRX Ltd aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.